Relmada Therapeutics, Inc. RLMD Defined Contribution Plan Cost Recognized
Defined Contribution Plan Cost Recognized at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DefinedContributionPlanCostRecognized.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s defined contribution plan cost recognized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s defined contribution plan cost recognized?
- Relmada Therapeutics, Inc. (RLMD) reported defined contribution plan cost recognized of $55.2K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s defined contribution plan cost recognized changed year-over-year?
- Relmada Therapeutics, Inc.'s defined contribution plan cost recognized increased by 15.7% year-over-year, from $47.7K to $55.2K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s defined contribution plan cost recognized?
- Over 2 years (2023 to 2025), Relmada Therapeutics, Inc.'s defined contribution plan cost recognized has grown at a 11.8% compound annual growth rate (CAGR), from $140.98K to $176.37K.
- What does defined contribution plan cost recognized mean?
- This metric represents the total expense recognized by the company during the reporting period for contributions made to employee defined contribution retirement plans. It provides insight into the company's recurring personnel-related overhead and the financial impact of its employee benefits program. Monitoring this cost helps investors understand the company's fixed operating expenses and its approach to managing human capital investments.